Výsledky vyhledávání - "Silvia Meola"

An Observational Study of Venlafaxine and CYP2D6 in Clinical Practice

Autor: Carla Gramaglia, Eugenio Torre, Valentina Dalo, F. Ressico, Matteo Vidali, Roberta Rolla, Silvia Meola, Paola Pollarolo, Patrizia Zeppegno, Pierluigi Prosperini, Giorgio Bellomo

Publikováno v: Università degli Studi del Piemonte Orientale-IRIS

BACKGROUND: Venlafaxine (V) is a serotonin-norepinephrine selective reuptake inhibitor, mainly metabolized by cytochrome P4502D6 (CYP2D6). CYP2D6 polymorphisms result in a variety of phenotypes: poor (PMs), intermediate (IMs), extensive (EMs), and ul

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::528cb2f371f3f08479a23e3c8b9dec21
https://doi.org/10.7754/clin.lab.2013.130141

Zobrazit plný text záznamu

Side effects associated with ultrarapid cytochrome P450 2D6 genotype among women with early stage breast cancer treated with tamoxifen

Autor: Nicolotti C, Giorgio Bellomo, Roberta Rolla, Matteo Vidali, Fanello Mr, Silvia Meola, Florian Stratica, Rossi, Paola Pollarolo, Saggia C, Borra G, Agostino Fd, Forti L, Alabiso O

Publikováno v: Università degli Studi del Piemonte Orientale-IRIS

BACKGROUND: The side effects of tamoxifen, a drug widely used for the treatment and the prevention of recurrence in patients with estrogen receptor positive breast cancers (ER+), have been reported in clinical trials, but to date no information is av

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a59da5618d057b24ee9daffb81f0cf0b
https://pubmed.ncbi.nlm.nih.gov/23289191

Zobrazit plný text záznamu

Estimating the cost of redundancy in molecular diagnostics: the case of activated protein C resistance and factor V Leiden

Autor: Roberta, Rolla, Matteo, Vidali, Silvia, Meola, Paola, Pollarolo, Patrizia, Pergolini, Giorgio, Bellomo

Publikováno v: Clinical laboratory. 57(9-10)

The activated protein C resistance--sensitivity ratio in the presence of Factor V deficient plasma (APC-SR/Factor V) exhibits a high sensitivity for factor V Leiden mutation and has been proposed as the diagnostic approach of choice, as an alternativ

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::77e724bfe23cc1229645b8f87b571d08
https://pubmed.ncbi.nlm.nih.gov/22029186

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání